Table 4. Mean GFR slope in chronic phase under models for nonlinear change

GroupMethod for Estimating GFRAcceleration (ml/min per yr/1.73 m2)Early Chronic Slope (ml/min per yr/1.73 m2)Late Chronic Slope (ml/min per yr /1.73 m2)Total Mean Slope from Baseline (ml/min per yr/1.73 m2)
MeanSEP ValueMeanSEMeanSEMeanSE
a Indicated parameter differed significantly between eGFR and iGFR (P < 0.05).
AlliGFR−0.280.110.01−1.690.20−2.340.16−1.980.11
eGFR−0.51a0.09<0.001−1.30a0.18−2.580.14−1.73a0.10
Low BPiGFR−0.110.150.45−1.850.28−2.030.22−2.080.16
eGFR−0.51a0.13<0.001−1.23a0.25−2.52a0.18−1.82a0.13
Usual BPiGFR−0.460.160.004−1.540.28−2.640.24−1.880.15
eGFR−0.510.09<0.001−1.300.18−2.580.14−1.730.10
MetoprololiGFR−0.090.140.49−1.910.29−2.020.22−2.270.16
eGFR−0.40a0.120.001−1.510.28−2.67a0.19−2.100.14
RamipriliGFR−0.330.140.02−1.190.30−2.130.23−1.750.16
eGFR−0.64a0.12<0.001−0.830.26−2.66a0.19−1.640.14
AmlodipineiGFR−0.570.370.12−2.280.54−3.400.53−1.860.31
eGFR−0.440.290.13−1.840.44−2.24a0.42−1.190.27a